Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

FTSE 100 movers: AstraZeneca in the black; Reckitt tumbles

(Sharecast News) - London's FTSE 100 was up 0.3% at 8,309.79 in afternoon trade on Monday. AstraZeneca was in the black as it hailed positive high-level results from a clinical trial of its Calquence treatment for adults with chronic lymphocytic leukaemia (CLL).

Entain fell as it said that BetMGM - its sports betting and iGaming operator in the US - surpassed the $1bn mark for revenues in the first half, but still made a loss as a result of heavy investments during the period.

Reckitt Benckiser was under the cosh amid concerns about potential litigation, after a US jury found on Friday that infant formula by Abbott Laboratories had caused a girl to develop a dangerous bowel disease.

Abbott was ordered to pay $495m in damages. This consisted of $95m compensatory damages and $400m punitive.

Dan Coatsworth, investment analyst at AJ Bell, said: "Reckitt's shares have been severely depressed since March as the market worries about the scale of any potential liabilities if the company loses legal battles around the safety of its baby formula.

"A US court case has already awarded $60 million in damages to a mother who said her baby died after consuming Reckitt's Enfamil baby formula. Several hundred similar claims have been in filed in US courts targeting Reckitt and Abbott.

"The more setbacks for either baby formula maker, the more complicated it becomes for Reckitt to sell its nutrition arm. Reckitt last week indicated it might be up for sale, saying it was considering all options for the business.

"Any potential buyer could be put off by the possibility of liabilities from the court cases, meaning the pressure is growing for Reckitt to find a way to ringfence a large amount of money in case it loses big time in the court battles."

BA and Iberia owner IAG flew lower ahead of half-year results at the end of the week.

FTSE 100 - Risers

Airtel Africa (AAF) 114.40p 4.19% SEGRO (SGRO) 918.60p 2.98% JD Sports Fashion (JD.) 126.95p 2.92% Prudential (PRU) 700.60p 2.28% NATWEST GROUP (NWG) 369.90p 2.21% AstraZeneca (AZN) 12,430.00p 1.92% 3i Group (III) 3,086.00p 1.92% M&G (MNG) 211.30p 1.88% Lloyds Banking Group (LLOY) 61.44p 1.76% Persimmon (PSN) 1,587.00p 1.73%

FTSE 100 - Fallers

Entain (ENT) 586.80p -9.58% Reckitt Benckiser Group (RKT) 4,065.00p -9.38% International Consolidated Airlines Group SA (CDI) (IAG) 164.50p -1.59% Fresnillo (FRES) 570.00p -1.55% Flutter Entertainment (DI) (FLTR) 15,150.00p -1.30% Anglo American (AAL) 2,357.00p -1.26% Burberry Group (BRBY) 738.00p -1.23% Diageo (DGE) 2,542.50p -0.90% Glencore (GLEN) 429.60p -0.87% Beazley (BEZ) 664.00p -0.67%

Share this article

Related Sharecast Articles

Europe midday: Shares mixed, oil rises on report of more US troops to Gulf
(Sharecast News) - European shares were mixed in cautious trade and oil prices rose on Wednesday as traders assessed a report that more US troops were being sent to the Gulf despite President Donald Trump's claims that peace talks with Iran could resume soon.
London midday: FTSE flattens out as investors eye fresh peace talks
(Sharecast News) - London stocks had flattened out by midday on Wednesday as investors mulled the potential resumption of US-Iran peace talks.
Asia report: Markets move higher on renewed Iran truce hopes
(Sharecast News) - Asia-Pacific markets broadly rose on Wednesday, tracking overnight gains on Wall Street as renewed hopes for a diplomatic breakthrough between the US and Iran lifted investor sentiment, although oil prices remained volatile amid lingering uncertainty.
Europe open: Shares up on peace talks hopes; Luxury stocks slump
(Sharecast News) - European shares edged higher in cautious trade as traders assessed US President Donald Trump's claims that peace talks with Iran could resume soon.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.